Author: Fiona Craig

Anglo American (LSE:AAL) and Chilean state-owned Codelco have finalized an agreement to jointly develop their neighboring copper mines, Los Bronces and Andina, in a deal projected to unlock at least $5 billion in value.

The collaboration will coordinate operations at both sites in central Chile through a joint mine plan, expected to add 2.7 million tonnes of copper production over 21 years once environmental permits are obtained, currently anticipated by 2030. The additional output is projected at around 120,000 tonnes annually, shared equally between the two companies.

The joint plan is expected to reduce unit costs by roughly 15% compared with operating the mines separately, with minimal additional capital investment required. The projected pre-tax net present value increase of $5 billion will be split equally between Anglo American Sur S.A., Anglo American’s 50.1%-owned subsidiary, and Codelco.

Combined production from Los Bronces and Andina in 2024 ranked the mines among the world’s top ten copper producers. The additional 120,000 tonnes per year under the joint plan would elevate them into the top five globally.

The agreement, unanimously approved by both boards, follows a memorandum of understanding signed in February 2025. A new jointly owned and controlled operating company will be established to implement the plan and optimize processing capacity across both mines. Each company will retain full ownership of its assets and continue operating its concessions independently.

Both Anglo American and Codelco will retain the ability to pursue separate projects, including underground expansions, during the agreement’s term. Anglo American Sur’s shareholders include the Anglo American group (50.1%), Mitsubishi Group (20.4%), and Becrux, a Codelco-Mitsui joint venture (29.5%).

The deal remains subject to regulatory and competition approvals, as well as obtaining environmental permits before the joint mine plan can be executed.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

SThree Plc (LSE:STEM) saw its shares fall more than 22% after reporting a 12% decline in third-quarter net fees, with weakness in Germany, the Netherlands, and the UK outweighing growth in the United States and Asia.

Group net fees for the quarter ending 31 August fell to £81.5 million from £92.7 million a year earlier. Contract fees, which account for 83% of total net fees, dropped 13% to £67.9 million, while permanent placements fell 5% to £13.6 million. The contractor order book decreased 6% to £156 million, representing roughly five months of fees. The company reported £42 million in net cash at the quarter’s end.

Regional performance was mixed. Net fees in the US rose 17% to £22.5 million, the Middle East and Asia increased 22% to £5.8 million, and Japan grew 20% to £3.8 million. However, major European markets showed steep declines: Germany fell 21% to £23.6 million, the Netherlands dropped 35% to £11.3 million, and the UK fell 27% to £7 million. Across the rest of Europe, fees were down 16%.

By sector, engineering remained largely stable with a 1% decline, while life sciences fell 12% and technology decreased 22%. Group headcount was 16% lower than a year earlier due to natural attrition and selective hiring as part of efficiency measures.

CEO Timo Lehne noted sequential improvement in performance and highlighted strong results in the US and Middle East and Asia. He also acknowledged ongoing challenges in European new business activity. Lehne emphasized the near-completion of the company’s Technology Improvement Programme and announced plans to increase investment in AI tools to boost efficiency and scalability.

While reaffirming guidance for FY25, the board cautioned that subdued activity is expected to continue into FY26, reflecting prolonged weakness in new business demand. The company also announced plans for a new share buyback program, with details expected early next year.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Trustpilot (LSE:TRST) reported solid momentum in the first half of 2025, achieving both revenue growth and improved profitability. Revenue rose 23% year-on-year to $122.8 million, or 21% at constant currency, while bookings increased 17% to $140 million. Annual recurring revenue grew 29% to $273 million.

Profit before tax rose 45% to $3.7 million, although reported EPS declined due to the absence of a one-off tax credit recorded last year. The company’s net dollar retention rate improved to 103% from 101%, supported by product innovation and expansion among enterprise customers.

Adjusted EBITDA jumped 70% to $18 million, with margins increasing four points to 14.6%. Adjusted free cash flow more than doubled to $15 million. Trustpilot highlighted record enterprise client wins, including Barclays, Boots, Lindt, and Vimeo, while customers paying over $20,000 annually have grown at a 38% CAGR over the past two years. Review volume increased 22% and TrustBox impressions rose 18% year-on-year.

CEO Adrian Blair commented, “Our H1 results demonstrate the momentum of our platform and the strength of our business model. Innovations such as AI review summaries and semantic search are meaningfully enhancing the consumer experience on Trustpilot.” He added that efficiency gains from expanded AI use contributed to improved margins and strong cash generation.

Trustpilot maintained its guidance for high-teens revenue growth and expects the full-year EBITDA margin to align with the first-half performance, exceeding expectations. The company also announced a new £30 million ($40 million) share buyback, reflecting strong cash generation.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

JTC Plc (LSE:JTC) reported that first-half profit fell 62.6% to £6.9 million, down from £18.5 million a year earlier, as acquisition-related costs and share-based payments offset higher revenue. Basic earnings per share came in at 4.16 pence, compared with 11.41 pence in H1 2024.

Reported EBITDA declined 11.8% to £41 million, while underlying EBITDA rose 15.1% to £56.5 million, with the underlying EBITDA margin broadly stable at 32.8% versus 33.4% a year earlier. Revenue grew 17.3% to £172.6 million, supported by record new business wins of £19.5 million and 11% net organic growth. The lifetime value of work won during the period was £267.8 million, based on an average client tenure of 14.2 years, providing visibility of more than £2.4 billion in future revenues.

The Institutional Capital Services division reported revenue of £104.2 million, up 19.1%, with underlying EBITDA of £31.3 million and a 30.1% margin. The Private Capital Services division generated £68.4 million in revenue, up 14.8%, with underlying EBITDA of £25.2 million and a margin of 36.8%.

Geographically, UK and Channel Islands revenue rose to £73.6 million from £66.7 million. In the US, revenue increased to £53.1 million from £46.4 million, representing 30.7% of the group’s total. Revenue in the rest of Europe grew to £20.9 million, and the rest of the world rose to £25 million from £14.3 million, reflecting recent acquisitions.

Net debt at June 30 was £250.7 million, compared with £150.5 million a year earlier, with leverage at 2.06 times underlying EBITDA, slightly above the company’s stated 1.5–2.0 range. Cash conversion was 86%, down from 104% last year. The board declared an interim dividend of 5 pence per share, up 16.3% from 4.3 pence in 2024, payable 24 October to shareholders on the register 26 September, with ex-dividend date 25 September.

After the reporting period, JTC completed the acquisition of Citi Trust on 1 July and announced the proposed purchase of Kleinwort Hambros Trust Company, expected to close in Q4 2025 and anticipated to be earnings accretive in 2026. Full-year expectations remain unchanged, with results expected to align with management guidance.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Google (NASDAQ:GOOGL) has inaugurated a new data centre near London, part of a £5 billion ($6.8 billion) investment to expand its AI-powered services and cloud infrastructure in the UK. The initiative reflects Google’s strategy to meet growing demand for services such as Google Cloud, Search, Maps, and Workspace.

The new facility, located in Waltham Cross, Hertfordshire, incorporates energy-efficient technologies, including air cooling systems and heat recycling. Google plans for its UK operations, including this site, to run on nearly 95% carbon-free energy by 2026. The company is also partnering with Shell PLC (LSE: SHEL) to support grid stability.

The investment is expected to create approximately 8,250 jobs per year across UK businesses during the rollout, supporting government efforts to attract private capital and strengthen digital infrastructure. Finance Minister Rachel Reeves attended the opening, describing the project as “a powerful vote of confidence in the UK economy.”

The development comes amid a global surge in AI and cloud investments by tech companies, intensifying competition in data centre deployment while raising discussions on environmental impact and infrastructure requirements.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

OptiBiotix Health plc (LSE:OPTI) delivered robust financial results for the first half of 2025, reporting a 102% increase in sales and a notable improvement in gross profit margin. The company has strengthened its market presence in the USA and Asia, launched new products, and established partnerships with global distributors.

A recent discovery of a new enzyme for SweetBiotix is expected to reduce manufacturing costs and broaden the product range. The company aims to achieve profitability and positive cash flow by continuing to expand sales, control costs, and improve margins.

About OptiBiotix Health

OptiBiotix Health plc is a life sciences company focused on developing products that modify the human microbiome to prevent and manage diseases and promote wellness. The company specializes in microbial strains, compounds, and formulations used as active ingredients and supplements, targeting obesity, cardiovascular health, and diabetes. OptiBiotix collaborates with international food and healthcare companies to integrate its microbiome modulators into a variety of foods and beverages.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Kier Group plc (LSE:KIE) announced robust financial results for the fiscal year ending 30 June 2025, with revenue up 3% and adjusted operating profit rising 6%. The company delivered strong operational performance across its divisions, strengthened its balance sheet, and expanded its order book to a record £11 billion, providing clear visibility of future revenues.

Kier also declared a 38% increase in its full-year dividend and launched a £20 million share buyback program. These achievements highlight the company’s strategic focus on sustainable growth, capital efficiency, and enhanced shareholder returns, positioning it to benefit from the UK Government’s infrastructure spending plans.

The company’s primary strengths lie in its solid financial performance and positive corporate developments, while technical indicators suggest some short-term market volatility. Valuation remains reasonable and in line with industry norms.

About Kier Group plc

Kier Group plc is a leading UK infrastructure services, construction, and property group. The company offers specialist design and build capabilities, leveraging its workforce’s knowledge, skills, and intellectual capital to manage and integrate all aspects of projects. Kier emphasizes sector-leading experience and innovative solutions, maintaining a local presence through offices across England, Wales, and Scotland.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Personal Group Holdings Plc (LSE:PGH) delivered robust financial results for the first half of 2025, achieving double-digit revenue growth and a 42% increase in adjusted EBITDA. Record insurance sales and an expansion of recurring revenue streams contributed to a 26% rise in the interim dividend. Strategic initiatives and new partnerships have broadened the company’s customer base, supporting its growth ambitions. Strong demand is also being driven by macroeconomic factors, as employers increasingly prioritize insurance and employee benefits.

The company’s outlook is underpinned by solid financial performance and effective strategic execution. Profitability and cash flow management remain strong, while technical indicators are generally bullish. However, a high RSI suggests potential overvaluation risks. Valuation metrics indicate a reasonable P/E ratio, complemented by a notably high dividend yield.

About Personal Group Holdings

Personal Group Holdings Plc is a UK-based provider of workforce benefits and services. The company focuses on enhancing employee engagement and supporting the physical, mental, social, and financial wellbeing of employees through health insurance and a broad range of benefits. Services are delivered via its proprietary app, Hapi, with plans to expand across SMEs, talent-driven organizations, and the public sector.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Eagle Eye Solutions Group PLC (LSE:EYE) announced its financial results for the year ending 30 June 2025, with group revenue rising 1% to £48.2 million, driven by an 11% increase in SaaS revenue. The company reached key milestones, including a major OEM agreement and the acquisition of Promotional Payments Solutions, strengthening its market presence.

Despite losing a contract with Neptune Retail Solutions, Eagle Eye secured new agreements across multiple regions, reinforcing its global customer base. The company remains optimistic about future growth, aiming to maintain a double-digit EBITDA margin and expand market reach through direct sales, partnerships, and OEM channels.

Eagle Eye Solutions benefits from solid financial performance and strategic corporate initiatives. Although technical indicators show potential bearish signals, the company’s undervaluation and proactive measures, such as share buybacks and acquisitions, support its market position.

About Eagle Eye Solutions

Eagle Eye is a leading SaaS and AI company that helps retail, travel, and hospitality brands build customer loyalty through real-time, omnichannel, and personalized marketing. Its technology combines scalable loyalty and promotions capabilities with AI to deliver personalized marketing at scale. Eagle Eye serves major clients including Loblaws, Asda, and Tesco, executing over 1 billion personalized offers weekly.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

EKF Diagnostics Holdings plc (LSE:EKF) posted record analyzer sales and improved earnings for the first half of 2025. Gross margins rose to 50.2%, and pre-tax profit increased by 16.1%. The company remains on track to meet full-year revenue and adjusted EBITDA growth targets, driven by strong performances in its Hematology and β-HB product lines.

Strategic initiatives are showing results, with expanded production capacity and a focus on high-margin products supporting profitability. EKF also completed a share buyback and canceled a loan facility, reflecting strong cash generation and a solid financial position.

EKF Diagnostics maintains a strong foundation, characterized by robust profit margins and low leverage. Technical indicators show a positive trend, though momentum remains moderate. Valuation appears fair based on the P/E ratio, although the absence of a dividend yield may limit appeal for income-focused investors.

About EKF Diagnostics Holdings

EKF Diagnostics Holdings plc is an AIM-listed global diagnostics company specializing in Point-of-Care analyzers, particularly for Hematology, Diabetes, and Life Sciences. It provides contract fermentation services for clinically important enzymes and proteins and manufactures Beta-Hydroxybutyrate (β-HB) for quantitative ketone testing and other clinical applications. Headquartered in Penarth near Cardiff, EKF operates five manufacturing sites across the US and Germany, distributing products to more than 120 countries worldwide.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.